Pricing Log in Create free account

eXoZymes Inc. (EXOZ) vs Lite Strategy, Inc. (LITS)

eXoZymes Inc. and Lite Strategy, Inc. are both Biotechnology companies. eXoZymes Inc. and Lite Strategy, Inc. are of similar size ($37.1M and $36.3M). Across the 10 metrics below, eXoZymes Inc. leads on 5 and Lite Strategy, Inc. on 5.

Valuation

Metric EXOZ LITS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.37 9.71
P/B 9.69 0.95 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.32 9.21
Earnings yield (29.10%) (179.62%) (33.15%)
Free cash flow yield (20.16%) (264.16%) (25.50%)

Profitability

Metric EXOZ LITS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (187.16%) (243.02%) (56.36%)
Return on assets (115.42%) (233.37%) (48.04%)
Return on invested capital 0.00% (115.85%) 0.00%

Growth

Metric EXOZ LITS Biotechnology median
Revenue growth (TTM) — 152.90% 6.02%
EPS growth (last fiscal year) (22.47%) 13.86% 30.26%
Revenue growth, 5-year CAGR — 67.75% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EXOZ LITS Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 3.81 5.74 4.72
Net debt to EBITDA 0.31 0.09 0.96

Dividend

Metric EXOZ LITS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EXOZ LITS Biotechnology median
Market cap 37.12m 36.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack